Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 50 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardio vascular segment (CVS), nutraceuticals and other oral and sterile products. Our pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms. We are globally present across 40+ countries through alliances and partnerships with globally reputed majors.
Our integrated business model enables us to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic segments. Our niche product basket helps us maintain an edge over our peers in the markets where we are present. In the years to come, driven by a highly competent and motivated team, we will move from strength to strength in the key domains of API, and global generics.
On March 31, 2020, the resolution plan under CIRP has been implemented and the Board has been re-constituted with the members nominated by Dhanuka Laboratories Limited, Haryana, India, the resolution applicant.
Corporate Insolvency Resolution Process of Orchid Pharma
We seek to build a sustainable organisational eco-system where one is constantly motivated to attain new heights and empowered to discover new avenues for growth.
Our Vision & Mission
Orchid is a vertically integrated pharmaceutical company with established research manufacturing and marketing capabilities across multi-therapeutic domain in healthcare.
Most organisations are mostly driven by strategies. We are also driven by values are Innovation. Corporate social responsibilty respect for the individual etc.